Onderneming HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Aandelen
HDST
IL0010954050
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 20-09-15 |
Tamar Raz
CHM | Chairman | 60 | 18-05-14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 31-08-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 29-07-18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 05-07-16 |
Orit Stav
BRD | Director/Board Member | 53 | 01-11-17 |
Tamar Raz
CHM | Chairman | 60 | 18-05-14 |
Merav Kaye
BRD | Director/Board Member | 50 | 28-09-14 |
Asher Elhayany
BRD | Director/Board Member | 71 | 26-12-22 |
Director/Board Member | 58 | 18-07-21 | |
Yuval Adar
BRD | Director/Board Member | 52 | 19-07-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 088 522 | 2 772 493 ( 25,00 %) | 0 | 25,00 % |
Bedrijfsgegevens
HBL- Hadasit Bio-Holdings Ltd.
Jerusaelm Bio-Park Hadassah Ein-Kerem Campus
91120, Jerusalem
+
http://www.hbl.co.ilSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |